186 related articles for article (PubMed ID: 38422022)
21. Factor-inhibiting hypoxia-inducible factor expression in patients with high-risk locally advanced renal cell carcinoma and its relationship with tumor progression.
Deng S; Zhang P; Zeng H; Wang W; Jin T; Wang J; Dong Q
Kaohsiung J Med Sci; 2014 Jan; 30(1):12-9. PubMed ID: 24388053
[TBL] [Abstract][Full Text] [Related]
22. Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1.
Shin DH; Chun YS; Lee DS; Huang LE; Park JW
Blood; 2008 Mar; 111(6):3131-6. PubMed ID: 18174379
[TBL] [Abstract][Full Text] [Related]
23. Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival.
Kiriakidis S; Henze AT; Kruszynska-Ziaja I; Skobridis K; Theodorou V; Paleolog EM; Mazzone M
FASEB J; 2015 Jul; 29(7):2814-27. PubMed ID: 25837583
[TBL] [Abstract][Full Text] [Related]
24. Nuclear entry and export of FIH are mediated by HIF1α and exportin1, respectively.
Wang Y; Zhong S; Schofield CJ; Ratcliffe PJ; Lu X
J Cell Sci; 2018 Nov; 131(22):. PubMed ID: 30333145
[TBL] [Abstract][Full Text] [Related]
25. Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.
Ma M; Hua S; Li G; Wang S; Cheng X; He S; Wu P; Chen X
Oncotarget; 2017 Feb; 8(8):12983-13002. PubMed ID: 28099905
[TBL] [Abstract][Full Text] [Related]
26. Knockout of Factor-Inhibiting HIF (
Schützhold V; Gravemeyer J; Bicker A; Hager T; Padberg C; Schäfer J; Wrobeln A; Steinbrink M; Zeynel S; Hankeln T; Becker JC; Fandrey J; Winning S
J Immunol; 2022 Mar; 208(5):1280-1291. PubMed ID: 35121641
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-31-5p enhances the Warburg effect via targeting FIH.
Zhu B; Cao X; Zhang W; Pan G; Yi Q; Zhong W; Yan D
FASEB J; 2019 Jan; 33(1):545-556. PubMed ID: 30004795
[TBL] [Abstract][Full Text] [Related]
28. FIH-1-Mint3 axis does not control HIF-1 transcriptional activity in nucleus pulposus cells.
Hirose Y; Johnson ZI; Schoepflin ZR; Markova DZ; Chiba K; Toyama Y; Shapiro IM; Risbud MV
J Biol Chem; 2014 Jul; 289(30):20594-605. PubMed ID: 24867948
[TBL] [Abstract][Full Text] [Related]
29. FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.
Kang J; Shin SH; Yoon H; Huh J; Shin HW; Chun YS; Park JW
Cancer Res; 2018 Mar; 78(5):1184-1199. PubMed ID: 29259012
[TBL] [Abstract][Full Text] [Related]
30. Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression.
Hyseni A; van der Groep P; van der Wall E; van Diest PJ
Cell Oncol (Dordr); 2011 Dec; 34(6):565-70. PubMed ID: 21732131
[TBL] [Abstract][Full Text] [Related]
31. MYPT1, the targeting subunit of smooth-muscle myosin phosphatase, is a substrate for the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH).
Webb JD; Murányi A; Pugh CW; Ratcliffe PJ; Coleman ML
Biochem J; 2009 May; 420(2):327-33. PubMed ID: 19245366
[TBL] [Abstract][Full Text] [Related]
32. The chromatin remodeler ISWI regulates the cellular response to hypoxia: role of FIH.
Melvin A; Mudie S; Rocha S
Mol Biol Cell; 2011 Nov; 22(21):4171-81. PubMed ID: 21900490
[TBL] [Abstract][Full Text] [Related]
33. Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase regulation in chronic kidney disease.
Faivre A; Dissard R; Kuo W; Verissimo T; Legouis D; Arnoux G; Heckenmeyer C; Fernandez M; Tihy M; Rajaram RD; Delitsikou V; Le NA; Spingler B; Mueller B; Shulz G; Lindenmeyer M; Cohen C; Rutkowski JM; Moll S; Scholz CC; Kurtcuoglu V; de Seigneux S
Nephrol Dial Transplant; 2023 Sep; 38(10):2276-2288. PubMed ID: 37096392
[TBL] [Abstract][Full Text] [Related]
34. The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity.
Masson N; Singleton RS; Sekirnik R; Trudgian DC; Ambrose LJ; Miranda MX; Tian YM; Kessler BM; Schofield CJ; Ratcliffe PJ
EMBO Rep; 2012 Mar; 13(3):251-7. PubMed ID: 22310300
[TBL] [Abstract][Full Text] [Related]
35. ABCE1 selectively promotes HIF-1α transactivation of angiogenic gene expression.
Sun L; Ding X; Kang YJ
J Trace Elem Med Biol; 2023 Dec; 80():127307. PubMed ID: 37738929
[TBL] [Abstract][Full Text] [Related]
36. Aspartyl-(asparaginyl) beta-hydroxylase, hypoxia-inducible factor-alpha and Notch cross-talk in regulating neuronal motility.
Lawton M; Tong M; Gundogan F; Wands JR; de la Monte SM
Oxid Med Cell Longev; 2010; 3(5):347-56. PubMed ID: 21150341
[TBL] [Abstract][Full Text] [Related]
37. Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau.
Lee C; Kim SJ; Jeong DG; Lee SM; Ryu SE
J Biol Chem; 2003 Feb; 278(9):7558-63. PubMed ID: 12482756
[TBL] [Abstract][Full Text] [Related]
38. Mint3 enhances the activity of hypoxia-inducible factor-1 (HIF-1) in macrophages by suppressing the activity of factor inhibiting HIF-1.
Sakamoto T; Seiki M
J Biol Chem; 2009 Oct; 284(44):30350-9. PubMed ID: 19726677
[TBL] [Abstract][Full Text] [Related]
39. Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha.
Lee YM; Lim JH; Chun YS; Moon HE; Lee MK; Huang LE; Park JW
Carcinogenesis; 2009 Oct; 30(10):1768-75. PubMed ID: 19696166
[TBL] [Abstract][Full Text] [Related]
40. Inverse solvent isotope effects arising from substrate triggering in the factor inhibiting hypoxia inducible factor.
Hangasky JA; Saban E; Knapp MJ
Biochemistry; 2013 Mar; 52(9):1594-602. PubMed ID: 23351038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
